Targeting inflammation to treat diabetic kidney disease: the road to 2030

S Rayego-Mateos, RR Rodrigues-Diez… - Kidney international, 2023 - Elsevier
Diabetic kidney disease (DKD) is one of the fastest growing causes of chronic kidney
disease and associated morbidity and mortality. Preclinical research has demonstrated the …

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases

Y Wang, J Hu, S Wu, JS Fleishman, Y Li, Y Xu… - … and Targeted Therapy, 2023 - nature.com
Ferroptosis, a unique modality of cell death with mechanistic and morphological differences
from other cell death modes, plays a pivotal role in regulating tumorigenesis and offers a …

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

X Wu, M Xu, M Geng, S Chen, PJ Little, S Xu… - Signal transduction and …, 2023 - nature.com
The ever-increasing prevalence of noncommunicable diseases (NCDs) represents a major
public health burden worldwide. The most common form of NCD is metabolic diseases …

Chronic kidney disease: strategies to retard progression

MT Yan, CT Chao, SH Lin - International journal of molecular sciences, 2021 - mdpi.com
Chronic kidney disease (CKD), defined as the presence of irreversible structural or
functional kidney damages, increases the risk of poor outcomes due to its association with …

Recent advances in diabetic kidney diseases: from kidney injury to kidney fibrosis

PH Hung, YC Hsu, TH Chen, CL Lin - International Journal of Molecular …, 2021 - mdpi.com
Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease and end-
stage renal disease. The natural history of DKD includes glomerular hyperfiltration …

Function and mechanism of histone β-hydroxybutyrylation in health and disease

T Zhou, X Cheng, Y He, Y Xie, F Xu, Y Xu… - Frontiers in …, 2022 - frontiersin.org
Histone post-translational modifications (HPTMs) are essential epigenetic mechanisms that
affect chromatin-associated nuclear processes without altering the DNA sequence. With the …

Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective

W Zheng, J Guo, ZS Liu - Clinical epigenetics, 2021 - Springer
Diabetic kidney disease (DKD) is one of the most common microvascular complication of
both type 1 (T1DM) and type 2 diabetes mellitus (T2DM), and the leading cause of end …

Renin-angiotensin system and inflammation update

E Cantero-Navarro, B Fernandez-Fernandez… - Molecular and cellular …, 2021 - Elsevier
The most classical view of the renin-angiotensin system (RAS) emphasizes its role as an
endocrine regulator of sodium balance and blood pressure. However, it has long become …

Sodium butyrate attenuates diabetic kidney disease partially via histone butyrylation modification

T Zhou, H Xu, X Cheng, Y He, Q Ren… - Mediators of …, 2022 - Wiley Online Library
Inflammation and fibrosis are the important pathophysiologic processes in diabetic kidney
disease (DKD), which is induced by epigenetics, especially histone posttranslational …

SGLT2 inhibitors in the treatment of diabetic kidney disease: more than just glucose regulation

J Klen, V Dolžan - Pharmaceutics, 2023 - mdpi.com
Diabetic kidney disease (DKD) is a severe and common complication and affects a quarter
of patients with type 2 diabetes mellitus (T2DM). Oxidative stress and inflammation related to …